Fas/Fasl表达与肺癌细胞凋亡关系的研究进展
被引量:2
出处
《山东医药》
CAS
北大核心
2006年第27期91-92,共2页
Shandong Medical Journal
基金
青岛市科技局资助项目(03-1-NY-14-2)
参考文献10
-
1Viard-Leveugle I, Veyrenc S,French LE,et al. Frequent loss of Fas expression and function in human lung tumours with over expression of FasL in small cell lung carcinoma [J]. Pathol,2003,201(2):268-277.
-
2Maher S,Toomey D, Condron C,et al. Activation induced cell death: thecontroversial role of Fas and Fas ligand in immune privilege and turnout conterattack[J]. Immunol Cell Biol,2002,80(2):131-137.
-
3Shin MS, Kim HS, Lee SH, et al. Alterations of Fas pathway genes associated with nodal metastasis in non small cell lung cancer[J]. Oncogene, 2002,21 (26) :4129-4136.
-
4Liu K,Scott I, Abrams SI, et al. Alterations in Fas expression are characteristic of, but not solely responsible for enhanced metastatic competence[J]. Immunol, 2003,170(12) : 5973-5978.
-
5Pluygers E, Sadowska A,Chyczewski L, et al. The impact of immune response on lung cancer and the development of new treatment modalities[J]. Lung Cancer,2001,34(Suppl2) :71-77.
-
6Cho D, Song H, Kim YM, et al. Endogenous interleukin 18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates[J].Cancer Res,2000,60(10):2703-2709.
-
7Raez LE, Cassileth PA,Schlesselman JJ ,et al. Allogeneic vaccination with a BT. 1 HLA-A gene-modified adenoeareinoma cell line in patients with advanced non-small-cell lung cancer[J].Clin Oncol,2004,22(14):2800-2807.
-
8江中勇,杨凌,陈清勇.Fas/FasL与肺癌关系的研究进展[J].国外医学(呼吸系统分册),2005,25(2):115-117. 被引量:4
-
9Odoux C,Albers A,Amoscato AA,et al. TRAIL,Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer[J]. Int J Cancer, 2002,97(4):458-465.
-
10时玉舫.细胞生物学与肿瘤免疫学研究进展[M].北京:军事医学科学出版社,2000,10—23.
二级参考文献16
-
1O'Connele LL,Bennett MW,O'Sullivan GC,et al.The Fascounter attack: cancer as a site of immuneprivilege.Immunol Today,1999,20(1):46-52.
-
2Shin MS,Kim HS,Lee SH,et al.Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer.Oncogene,2002,21(26):4129-4136.
-
3Bernstorff WV,Spamjaard RA,Chan AK,et al.Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas(Apo-1/CD95) recepors and sberrant expression of functional Fas ligand.Surgery,1999,125(1):73-84.
-
4Bennett MW,O'Connele LL,O'Sullivan GC,et al.The Fascounter attack in vivo:apoptotic depletion of tumor infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.J Immunol,1998,160(11):5669-5675.
-
5Arai H,Chan SY,Bishop DK,et al.Inhibition of the alloantibody response by CD95 ligand.Nat Med,1997,3(8):843-848.
-
6Rabinowich H,Reichert TE,Kashii Y,et al.Lymphocyte apoptosis induced by Fas ligand-expressing Ovarian carainoma cells.J Clin Invest,1998,101(11):2579-2588.
-
7Cho D,Song H,Kim YM,et al.Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates.Cancer Res,2000,60(10):2703-2709.
-
8Viard-Leveugle I,Veyrenc S,French LE.Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.J Pathol,2003,201(2):268-277.
-
9Dong Xilin,Dong Lei,Li Xiuxia,et al.The expression and Clinical Significance of Fas and FasL in Lung Cancer.J Med University,2003,17(3):122-128.
-
10Odoux C,Albers A,Amoscato AA,et al.TRAIL,FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.Int J Cancer,2002,97(4):458-465.
共引文献3
-
1汪进良,焦顺昌,胡毅,李瑾昱.重组人p53腺病毒联合顺铂对肺腺癌A549细胞基因表达的影响[J].中国医学科学院学报,2010,32(4):383-388. 被引量:5
-
2赵志强,李广太.凋亡蛋白Bcl-2、Fas在外阴白色病变的表达[J].齐齐哈尔医学院学报,2006,27(10):1153-1155. 被引量:2
-
3佟书娟,许冬青,詹瑧.舌苔形成与Fas基因表达关系的初步研究[J].中国中医基础医学杂志,2007,13(10):753-754. 被引量:8
同被引文献11
-
1仲宁,李玉芳,郑世营,陈锁成.Fas/FasL在肺癌中的表达[J].现代肿瘤医学,2005,13(1):36-39. 被引量:2
-
2李静岩.Caspase-3与肿瘤关系的研究[J].医学综述,2005,11(5):430-432. 被引量:29
-
3王靖华,陈龙邦,黄文斌,李桂圆,孟奎,管晓翔,王晨.survivin和caspase-3在非小细胞肺癌中的表达及其与肿瘤细胞凋亡的关系[J].中国肺癌杂志,2005,8(5):435-439. 被引量:21
-
4邹悦,魏煜程,沈毅.非小细胞肺癌患者手术前后血清可溶性Fas和FasL浓度的变化及其临床意义[J].中华肿瘤防治杂志,2006,13(11):841-843. 被引量:4
-
5Muppidi JR, Siegel RM. Ligand - independent redistribution of Fas( CD95 ) into lipid rafts mediates clonotypic T cell death [ J]. Nat Immunol,2004,5 (2) :182 -189.
-
6Pluygers E, Sadowska A, Chyezewski L, et al. The impact of immune response on lung cancer and the development of new treatment modalities[ J]. Lung Cancer,2001,34( Suppl 2) :71 -77.
-
7Robertson GS, Crocker SJ, Nicholson DW, et al. Neuroprotection by the inhibition of apoptosis[ J]. Brain Pathol, 2000, 10(2) : 283 - 292.
-
8Hishikawa K, Nakaki T, Fujii T. Connective tissue growth factor induce apoptosis via Caspase -3 in culturel human aortic smooth muscle cells [J]. Eur J Pharmacol,2000,392 ( 1 - 2 ) : 19 - 22.
-
9Shin MS, Kim HS, Lee SH, et al. Alterations of Fas - pathway genes associated with nodal metastasis in non - small cell lung cance[J]. Oncogene ,2002, 21 (26) :4129 - 4136.
-
10许学文,宋彦,由凯,宋永胜.进展性前列腺癌中Fas和Survivin的表达及其相关性研究[J].现代肿瘤医学,2009,17(1):71-73. 被引量:4
二级引证文献22
-
1王红梅,张国强,戴纪纲,闵家新.人淋巴瘤细胞Jurkat通过Fas/FasL途径抑制人肺癌细胞A549的免疫逃逸[J].中国肺癌杂志,2010,13(7):681-685. 被引量:7
-
2张雪梅,滕琳,刘启明,霍荣昌.PDCD5与Caspase-3在人非小细胞肺癌中的表达[J].现代肿瘤医学,2010,18(8):1533-1536. 被引量:10
-
3王昌明,黎洪秀,张孝飞.Fas及FasL和Caspase-3在青蒿琥酯诱导人胚肺成纤维细胞凋亡中的表达(英文)[J].中国组织工程研究与临床康复,2011,15(20):3785-3788. 被引量:11
-
4仲广生,李孟圈,苏静.乳腺浸润性导管癌中Paxillin和Caspase-3蛋白的表达及临床意义[J].中国肿瘤临床,2012,29(1):22-25. 被引量:1
-
5李小艳,包素珍.Caspase家族的研究进展[J].内蒙古中医药,2012,31(2):107-107. 被引量:14
-
6龚淼,李莉,包宪霞,孟丽,张亚楠,郭浅妤,赵昱,张雷.姜黄素对体外培养的人食管癌Ec-109细胞增殖和凋亡的影响[J].河北医科大学学报,2012,33(2):125-128. 被引量:2
-
7夏如民,唐均英,赵雪,郭飞,王建,姚陈果.纳秒级陡脉冲诱导人卵巢癌细胞凋亡及对Fas介导的细胞凋亡通路的影响[J].生物医学工程学杂志,2012,29(6):1144-1149. 被引量:1
-
8邢海杰,廖晶.FAS在下咽鳞癌中的表达及临床病理意义[J].武汉大学学报(医学版),2013,34(1):31-34.
-
9石国钰,吴立平,李奎英,康保洁.Maspin与Caspase-3在人非小细胞肺癌中的表达[J].青岛医药卫生,2013,45(1):29-32. 被引量:1
-
10赵丹,罗星,杨晓萍.1,25(OH)_2D_3上调Caspase-3表达诱导大鼠系膜细胞凋亡的研究[J].中国现代医学杂志,2013,23(34):1-4. 被引量:1
-
1林静,于淑霞,戴洁,王超,姚希贤.BCL-2,Fas基因蛋白在胃癌及癌前病变组织中的表达[J].胃肠病学和肝病学杂志,1999,8(1):27-29. 被引量:1
-
2张妍,张文颖,周玲,王莉.Fas/FasL在宫颈癌组织中的表达及意义[J].中国实验诊断学,2011,15(12):2126-2127. 被引量:2
-
3胡风标,郑金锋.非小细胞肺癌组织中CD_(44s)、CD_(44v6)、Fas的表达及意义[J].山东医药,2013,53(38):39-41. 被引量:4
-
4吴式琇,俞康,谢聪颖,孙成超.Fas/FasL在肺癌中的表达与淋巴结转移的关系[J].肿瘤防治研究,2001,28(2):119-120. 被引量:3
-
5李玉中,王朝晖,吕申,王乃玉.在HBV感染的肝癌组织中Fas/FasL表达的作用[J].中国微生态学杂志,2006,18(5):363-364.
-
6谢聪颖,吴式琇,俞康.Fas/FasL在肺癌中的表达及意义[J].中国癌症杂志,2002,12(1):29-30. 被引量:1
-
7朱强,刘吉勇,杨崇美,张安忠,崔屹.全反式维甲酸对结肠癌细胞Fas/FasL表达的影响[J].中华消化杂志,2003,23(9):539-539.
-
8杨开颜,俞康,李剑敏,黄卡特.鳞癌与基底细胞癌的Fas/FasL表达及其与细胞凋亡的关系[J].癌变.畸变.突变,2003,15(4):215-216. 被引量:5
-
9韦兵,王元星,贺大璞,龙超众.食管鳞癌Fas/FasL的表达及意义[J].中国现代医学杂志,2010,20(15):2313-2314.
-
10段云,王淑珍,梁韶春.慢性胃炎、胃癌及溃疡患者Fas/FasL的表达[J].山东医药,2005,45(22):69-69. 被引量:1